City Council

7.c. CONSIDERATION AND APPROVAL OF RESOLUTION NO. 23-30,\nAPPROVING AUTHORIZATION TO ENTER INTO ADDITIONAL NATIONAL\nOPIOID SETTLEMENTS WITH TEVA, ALLERGAN, WALMART, WALGREENS,\nAND CVS\nAt this time, a new settlement is proposed with Teva, Allergan, Walmart,\nWalgreens, and CVS, who are additional defendants that are retailers and\nmanufacturers of opioids (for the purposes of this submittal, Teva, Allergan,\nWalmart, Walgreens, and CVS are collectively referred to as the “2023 Settling\nDefendants”). The terms of the 2023 Settlement Agreements are similar to the\n2021 Settlement Agreements, which includes the requirement that a critical mass\nof participation is required, provides for a broad release of the 2023 Settling\nDefendants from liability relating to opioids, and, further, direct or indirect\npayment of settlement funds to the various local agencies agreeing to participate.\nRECOMMENDED ACTION: Staff recommends City Council:\n1. Approve Settlement Agreements and Participation Forms for the City’s\nparticipation in the National Opioid Settlement Agreements with Teva,\nAllergan, Walmart, Walgreens, and CVS;\n2. Approve the California State-Subdivision Agreements Regarding Distribution\nand Use of Settlement Funds relating to the National Opioid Settlement\nAgreements with Teva, Allergan, Walmart, Walgreens, and CVS; and\n3. Adopt Resolution No. 23-30, approving and authorizing the City Manager to\ncarry out all necessary acts such that the City can participate in the National\nOpioid Settlements with Teva, Allergan, Walmart, Walgreens, and CVS,\nincluding signing necessary documents and transmittal thereof as necessary.